Skip to main content
SpringerLink
Log in

The poor-responder patient in an in vitro fertilization-embryo transfer program

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ben Rafael Z, Menashe Y, Mimon R, Lipitz S, Bider D, Zolti Z, Dan U, Pariente C, Shalev J, Dor J, Lev-Ran D, Mashiach S: Limitations in the use of combined gonadotropin releasing hormone analog and human menopausal gonadotropin for in vitro fertilization.In Advances in Assisted Reproductive Technologies, S Mashiach, Z Ben Rafael, N Laufer, JA Schenker (eds.). New York, London, Plenum Press, 1990, pp 17–29

    Google Scholar 

  2. Scott TR, Toner PJ, Muasher SJ, Oehninger S, Robinson SH, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651

    PubMed  Google Scholar 

  3. Tanbo T, Dale PO, Lunde O, Norman N, Abyholm J: Prediction of response to controlled ovarian hyperstimulation: A comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 1992;57:819

    PubMed  Google Scholar 

  4. Navot D, Rosenwaks Z, Margalioth EJ: Prognostic assessment of female fecundity. Lancet 1987;2:645

    PubMed  Google Scholar 

  5. Pellicer A, Lightman A, Diamond MP, Russell JB, de Cherney A: Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 1987;47:812

    PubMed  Google Scholar 

  6. Ben Rafael Z, Strauss JF, Mastroianni L, Flickinger GL: Differences in ovarian stimulation in human menopausal gonadotropin treated women may be related to FSH accumulation. Fertil Steril 1986;46:586

    PubMed  Google Scholar 

  7. Benadiva CA, Ben Rafael Z, Strauss JF, Mastroianni L, Flickinger GL: Ovarian response of individuals to different doses of human menopausal gonadotropin. Fertil Steril 1988;49:997

    PubMed  Google Scholar 

  8. Ben Rafael Z, Benadiva CA, Ausmanas M, Barber B, Blasco L, Flickinger GL, Mastroianni L: Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril 1987;48:964

    PubMed  Google Scholar 

  9. Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W, Huynn D: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51:455

    PubMed  Google Scholar 

  10. Droesch K, Muasher ST, Brzyski R, Jones SG, Simonetti S, Liu HCH, Rosenwaks Z: Value of suppression with a GnRH-a prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292

    PubMed  Google Scholar 

  11. Serafini P, Stone B, Kerin J, Banrofin J, Quinn P, Marrs R: An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropinreleasing hormone analog. Fertil Steril 1988;49:90

    PubMed  Google Scholar 

  12. Padilla SL, Bayat J, Garcia J: Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 1990;53:288

    PubMed  Google Scholar 

  13. Adashi EY, Resnick CE, Hernandez ER, Hurwitz A, Roberts CT, LeRioth D, Rosenfeld R: Insulin like growth factor I as an intra-ovarian regulator: basic and clinical implications. Ann NY Acad Sci 1991;626:161

    PubMed  Google Scholar 

  14. Homburg R, Eshel A, Abdulla HI, Jacobs HS: Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol 1988;29:113

    Google Scholar 

  15. Coukos G, Artini PG, Volpe A, Silferi M, Barreca A, Minuto F, Genazzani GR: Improvement of ovarian response to induction of superovulation with combined growth hormonegonadotropin treatment.In Advances in Assisted Reproductive Technologies, S Mashiach, Z Ben Rafael, N Laufer, JA Schenker (eds). New York, London, Plenum Press, 1990, p 389

    Google Scholar 

  16. Ibrahim ZHZ, Lieberman BA, Matson PL, Buck P: The use of biosynthetic growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotrophin during controlled ovarian hyperstimulation for in vitro fertilization in women with a poor ovarian response. Fertil Steril 1991;55:202

    PubMed  Google Scholar 

  17. Owen EJ, West C, Mason BA, Jacobs HS: Co-treatment with growth hormone of sub-optimal responders in IVF-ET. Hum Reprod 1991;6:529

    PubMed  Google Scholar 

  18. Feldberg D, Ashkenazi J, Shelef I, Voliovich I, Ben-Rafael Z: Minidose GnRH is the treatment of choice in poor responders with high FSH levels in an IVF program. 48th Annual Meeting of the American Fertility Society, New Orleans, LA, Oct 31–Nov 5, 1992, abstr

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Golda Medical Center (Hasharon Hospital) Sackler School of Medicine Tel Aviv University, Petah Tikva, Israel

    Zion Ben-Rafael & Dov Feldberg

Authors
  1. Zion Ben-Rafael
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dov Feldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ben-Rafael, Z., Feldberg, D. The poor-responder patient in an in vitro fertilization-embryo transfer program. J Assist Reprod Genet 10, 118–120 (1993). https://doi.org/10.1007/BF01207732

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01207732

Search

Navigation